¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Severance Cardio-Cerebrovascular Research Cluster International Symposium 2021 : 2021-12-17 |
|
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Severance Cardio-Cerebrovascular Research Cluster International Symposium 2021 : 2021-12-17 ±³À°ÀÏÀÚ : 2021-12-17 ±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°ÁÖÁ¦ : Severance Cardio-Cerebrovascular Research Cluster International Symposium 2021 ÁÖÃÖ±â°ü : ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ´ã´çÀÚ : ÀÓÀºÁö ¿¬¶ôó : 02-2228-0712 À̸ÞÀÏ : limeunji@yuhs.ac ±³À°Á¾·ù : ½Å°æ°ú±âŸ Âü¼®¿¹»óÀοø : 250¸í Èñ¸ÁÆòÁ¡ : 4Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 4 ½Ã°£ 15ºÐ ¼¼ºÎ¼ö°·á : 0¿ø ºñ°í ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 10:00~10:20 In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates Kiran Musunuru(University of Pennsylvania USA) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 10:20~10:40 Latest on genome engineering using CRISPR Cas 9 system ±èÇü¹ü(¿¬¼¼ÀÇ´ë ¾à¸®Çб³½Ç) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 10:40~11:00 Antisense inhibition of angiotensinogen to treat hypertension and heart failure Sotirios Tsimikas(UC San Diego USA) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 11:00~11:30 Blood Pressure Management within the ecosystem Yuichiro Yano(Duke University Durham NC USA; Yokohama City University Hospital Japan) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 11:30~11:45 Lifestyle modification for better Blood Pressure Control ½ÉÁö¼±(¿¬¼¼ÀÇ´ë ¿¹¹æÀÇÇб³½Ç) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 11:45~12:00 Out of office BP measurement for hypertension screening ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë ³»°úÇб³½Ç) ½Ä»ç 12-17 ¿Â¶óÀÎ 12:00~13:00 () ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 13:00~13:15 Deep learning on Multiphysical Features for Abdominal Aortic Aneurysm Growth Prediction ±è¼¼±Ù(CONNECT-AI ¿¬±¸¼¾ÅÍ) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 13:15~13:30 Development of predictive model for diagnosis and prognosis of pulmonary arterial hypertension based on hemodynamics using deep learning Çϼº¹Î(CONNECT-AI ¿¬±¸¼¾ÅÍ) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 13:30~13:45 CT Radiomics Features for Coronary Artery Disease È«¿µÅÃ(CONNECT-AI ¿¬±¸¼¾ÅÍ) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 13:45~14:00 Deep Learning framework for Phonocardiogram À念°É(CONNECT-AI ¿¬±¸¼¾ÅÍ) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 14:00~14:25 ½É³úÇ÷°üÁúȯ ¿¹¹æ°ü¸® ¹× ±Øº¹À» À§ÇÑ ±¹°¡ R&D ÃßÁø Àü·« ±è¿øÈ£(Áúº´°ü¸®Ã» ±¹¸³º¸°Ç¿¬±¸¿ø ½ÉÇ÷°üÁúȯ¿¬±¸°ú) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 14:25~14:50 Survival advantage and progressive genetic alteration in human embryonic stem cells with 20q11.21 CNV Â÷ÇõÁø(¼¿ï´ëÇб³ ¾àÇдëÇÐ) ±³À°½Ã°£ 12-17 ¿Â¶óÀÎ 14:50~15:15 ÀÓ»ó¿ë Áٱ⼼Æ÷Ä¡·áÁ¦ÀÇ Á¦Á¶ ¹× Ç°Áú°ü¸® Á¤Áø±¹(Áúº´°ü¸®Ã» ±¹¸³º¸°Ç¿¬±¸¿ø ³Ä¡¼ºÁúȯ¿¬±¸°ú) |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 481 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 259 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 395 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 512 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 464 , ´ñ±Û¼ö : 0 |